Penserra Capital Management LLC Purchases 12,555 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Penserra Capital Management LLC lifted its position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 22.8% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 67,714 shares of the real estate investment trust’s stock after buying an additional 12,555 shares during the quarter. Penserra Capital Management LLC’s holdings in Sabra Health Care REIT were worth $1,260,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co grew its holdings in Sabra Health Care REIT by 2.9% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 215,824 shares of the real estate investment trust’s stock worth $3,183,000 after acquiring an additional 5,985 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Sabra Health Care REIT by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,630 shares of the real estate investment trust’s stock worth $1,812,000 after purchasing an additional 8,554 shares during the last quarter. EMC Capital Management grew its stake in shares of Sabra Health Care REIT by 6.2% in the first quarter. EMC Capital Management now owns 23,972 shares of the real estate investment trust’s stock worth $354,000 after purchasing an additional 1,400 shares during the last quarter. Cetera Investment Advisers increased its holdings in Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust’s stock valued at $6,007,000 after purchasing an additional 103,413 shares during the period. Finally, Cetera Advisors LLC raised its position in Sabra Health Care REIT by 996.2% during the 1st quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust’s stock worth $2,209,000 after purchasing an additional 135,929 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock opened at $18.84 on Wednesday. The stock has a market capitalization of $4.46 billion, a price-to-earnings ratio of 45.95, a PEG ratio of 2.31 and a beta of 1.25. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $20.03. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The stock’s 50 day moving average price is $18.63 and its two-hundred day moving average price is $16.73.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the prior year, the company earned $0.34 earnings per share. On average, equities analysts predict that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.37%. Sabra Health Care REIT’s dividend payout ratio is presently 292.68%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Scotiabank increased their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. Truist Financial increased their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Sabra Health Care REIT currently has an average rating of “Moderate Buy” and an average price target of $18.71.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.